Answers are grounded in this paper and cite their sources.
Postoperative TAC injections do not reduce the number of keloid recurrences. However, injection of keloid excision sites with IFN-alpha 2b offers a therapeutic advantage over keloid excision.
No takes yet. Share an insight, caveat, or question.
Berman et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: